AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
NASDAQ · Healthcare · Biotechnology · CN
$17.62
+1.47%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.88x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 19.83x
- Price / sales
- 10.78x
- Price / cash flow
- -7.03x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- 10.99x
- EV / EBITDA
- -4.80x
- EV / EBIT
- -4.49x
- Market cap
- $1.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026